NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the Guide
Join the QualityMetric science team for three presentations you won’t want to miss during this year’s ISOQOL Conference.
Michelle White, Vice President, Consulting Science Services & Senior Scientist, QualityMetric will present:
Wednesday, October 19th 10:30am-12:00pm (CEST)
During the Industry Special Interest Group Symposium
Jakob Bjorner, Chief Scientific Officer, QualityMetric will present:
Saturday, October 22nd 8:30am (CEST)
During Symposium 04
Meaghan O’Connor, MTS, MPH, QualityMetric
Saturday, October 22nd 4:10-5:40pm (CEST)
During the Oral Session 302, Qualitative Methods in the Development and Application of PROs
*This presentation includes work done by scientific mastermind QM’ers: Lynne Broderick, Kaitlin LaGasse, Kristen McCausland, and Michelle White
As the gold standard in scientifically validated patient-reported outcomes (PRO) surveys QualityMetric is honored to sponsor ISOQOL 2022 with this year’s theme, Redefining Boundaries – breaking new ground in patient-centered outcomes research
For more information on ISOQOL 29th Annual Conference visit: 29th Annual Conference | ISOQOL
We look forward to seeing old friends and meeting new.
QM believes in an end-to-end approach when it comes to helping clients put together their evidence generation plans. Whether for regulatory or exploratory end points, QM patient-reported outcomes (PRO) and clinical assessment outcome (COA) surveys can illuminate how specific disease conditions impact patients.
Visit to learn more about our end-to-end approach and rare disease expertise: Rare Disease Expertise at QualityMetric | We Measure Health.